“Standard of Care” for MBC
What does “standard of care” mean and how is it used in clinical trials? Find in this issue of Metastatic Breast Cancer Talk.
Understanding Informed Consent
Your “Informed Consent” is required for all trials. Learn more about this process.
What are Solid Tumor Trials and Why Are They Important?
Find solid tumor trials that might be right for you.
Metastatic Trial Search: New Features
See what’s new on Metastatic Trial Search — and find a trial that’s right for you.
FDA Fast Track
FDA Fast Track is a program to accelerate the development, review, and approval of new drugs to fill an unmet medical need. Read more about FDA Fast Track.
Just-in-Time Trials
“Just-in-Time” trials are designed to be opened easily and quickly at any site where an eligible patient is identified. Learn how they work, and how they benefit both patients and investigators.
Expanded Access
Investigational drugs may be available outside of a clinical trial. Read more about the Expanded Access program.
What You Need to Know About Washout Periods
A washout period describes the length of time that someone enrolled in a trial must not receive any treatment before receiving the trial’s experimental treatment. Click to learn about why washout periods are required, as well as concerns and potential solutions.
What Are Lines of Therapy and What You Need to Know
“Lines of therapy” describes the order in which therapies are given as MBC progresses. Learn how lines of therapy are chosen and about current MBC treatment guidelines.
MBC, Advanced Breast Cancer & Locally Advanced Breast Cancer: What’s in a Name?
Do you know what are advanced breast cancer, locally advanced breast cancer, or metastatic breast cancer in clinical trial eligibility criteria? Learn the terminologies here.